interleukin-18

Expression system: E. coli
Length: 37-193, Full Length of Mature Protein
Activity: Not Tested

IL-18 Protein, Canine, Recombinant (His) is expressed in E. coli. The accession number is Q9XSR0.

Expression system: HEK293 Cells
Length: 37-193, Full Length of Mature Protein
Activity: Not Tested

Expression system: E. coli
Length: 36-192, Full Length of Mature Protein
Activity: Not Tested

IL-18 Protein, Rat, Recombinant is expressed in E. coli. The accession number is P97636-1.

Expression system: E. coli
Length: 2-193, Partial
Activity: Not Tested

Expression system: E. coli
Length: 36-192, Full Length of Mature Protein
Activity: Cells Activity

Expression system: E. coli
Length: 1-193, Full Length
Activity: Not Tested

Expression system: HEK293 Cells
Length: 29-193, Full Length of Mature Protein
Activity: Not Tested

Expression system: HEK293 Cells
Length: 31-194, Full Length of Mature Protein
Activity: Not Tested

Expression system: HEK293 Cells
Length: 20-356, Partial
Activity: Not Tested

Expression system: E. coli
Length: 1-495, Full Length
Activity: Not Tested

Expression system: E. coli
Length: 18-202, Partial
Activity: Not Tested

Expression system: E. coli
Length: 37-193, Full Length of Mature Protein
Activity: ELISA

Expression system: HEK293 Cells
Length: 31-194, Full Length of Mature Protein
Activity: SPR

Expression system: E. coli
Length: 117-269, Full Length of Mature Protein
Activity: ELISA、SPR

Expression system: E. coli
Length: 117-269, Full Length of Mature Protein
Activity: ELISA

Expression system: HEK293 Cells
Length: 19-329, Partial
Activity: SPR

Expression system: HEK293 Cells
Length: 19-329, Partial
Activity: SPR

Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. IL-18BP Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 21.14 kDa and the accession number is A0A2K5UDJ4.

Cytokines were the first modern immunotherapies to produce durable responses in patients with advanced cancer,components of the interleukin-18 (IL-18) pathway are upregulated on tumour-infiltrating lymphocytes, suggesting that IL-18 therapy could enhance anti-tumour immunity. IL-18BP, a high-affinity IL-18 decoy receptor, is frequently upregulated in diverse human and mouse tumours and limits the anti-tumour activity of IL-18 in mice. IL-18BP Protein (Primary Amine Labeling), Cynomolgus, Recombinant (His), Biotinylated is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 21.14 kDa and the accession number is A0A2K5UDJ4.

Interleukin-18 (IL-18) is a member of the interleukin-1 family of cytokines produced constitutively by different cell types and by adipose tissue. Interleukin (IL)-18 was originally discovered as a factor that enhanced IFN-γ production from anti-CD3-stimulated Th1 cells, especially in the presence of IL-12. Upon stimulation with Ag plus IL-12, naïve T cells develop into IL-18 receptor (IL-18R) expressing Th1 cells, which increase IFN-γ production in response to IL-18 stimulation. IL-18R alpha Protein, Cynomolgus, Recombinant (aa 22-329, His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 36.45 kDa and the accession number is A0A2K5V3J9.

Interleukin-1 beta (IL-1β) is induced by inflammatory signals in a broad number of immune cell types. IL-1β (and IL-18) are the only cytokines which are processed by caspase-1 after inflammasome-mediated activation. IL-1 signaling activates innate immune cells including antigen presenting cells, and drives polarization of CD4 T cells towards T helper type (Th) 1 and Th17 cells. IL-1 beta IL-1F2 Protein, Cynomolgus, Recombinant (His) is expressed in E. coli expression system with C-His tag. The predicted molecular weight is 18.33 kDa and the accession number is A0A2K5VDC7.

The cytokine interleukin-22 (IL-22) is a critical regulator of epithelial homeostasis. It has been implicated in multiple aspects of epithelial barrier function, including regulation of epithelial cell growth and permeability, production of mucus and antimicrobial proteins (AMPs), and complement production. IL-22 Protein, Cynomolgus, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 17.69 kDa and the accession number is G7PHZ7.